AngioDynamics (ANGO) News Today $8.89 +0.31 (+3.61%) (As of 12/20/2024 05:31 PM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period AngioDynamics to Report Fiscal 2025 Second Quarter Financial Results on January 8, 2025 and Host Virtual NanoKnife Investor EventDecember 19 at 5:00 PM | businesswire.comContrasting AngioDynamics (NASDAQ:ANGO) & West Pharmaceutical Services (NYSE:WST)December 17, 2024 | americanbankingnews.comXTX Topco Ltd Buys Shares of 74,816 AngioDynamics, Inc. (NASDAQ:ANGO)XTX Topco Ltd purchased a new position in shares of AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 74,816 shares of the medical iDecember 13, 2024 | marketbeat.comAngioDynamics Receives FDA Clearance for NanoKnife System, Poised for Growth with New Market Opportunities and Clinical SuccessDecember 11, 2024 | markets.businessinsider.comAngioDynamics (NASDAQ:ANGO) Given Buy Rating at HC WainwrightDecember 11, 2024 | americanbankingnews.comAnalysts Are Bullish on Top Healthcare Stocks: AbbVie (ABBV), Protagonist Therapeutics (PTGX)December 10, 2024 | markets.businessinsider.comAngioDynamics, Inc. (NASDAQ:ANGO) Stock Position Lifted by BNP Paribas Financial MarketsBNP Paribas Financial Markets lifted its position in AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) by 110.4% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 159,391 shares of the medical instrumeDecember 10, 2024 | marketbeat.comNanoKnife gains FDA clearance for prostate tissue ablationDecember 9, 2024 | finance.yahoo.comAngioDynamics Shares at 52-Week High After FDA Clears NanoKnifeDecember 9, 2024 | marketwatch.comAngioDynamics receives FDA 510(k) clearance for NanoKnife SystemDecember 9, 2024 | tipranks.comAngioDynamics Receives FDA Clearance for The NanoKnife® System for Prostate Tissue AblationDecember 9, 2024 | businesswire.comJacobs Levy Equity Management Inc. Reduces Stock Holdings in AngioDynamics, Inc. (NASDAQ:ANGO)Jacobs Levy Equity Management Inc. lowered its holdings in shares of AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) by 18.7% in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 414,120 shares of the medical instruments supplier'December 7, 2024 | marketbeat.comSystematic Financial Management LP Grows Position in AngioDynamics, Inc. (NASDAQ:ANGO)Systematic Financial Management LP grew its holdings in AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) by 14.3% during the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 2,410,346 shares of the medical instDecember 5, 2024 | marketbeat.comAngioDynamics, Inc. (NASDAQ:ANGO) Position Boosted by Segall Bryant & Hamill LLCSegall Bryant & Hamill LLC boosted its position in AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) by 142.7% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 911,443 shares of the medical instruments suppliNovember 22, 2024 | marketbeat.comAngioDynamics, Inc. (NASDAQ:ANGO) Shares Purchased by Royce & Associates LPRoyce & Associates LP grew its holdings in shares of AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) by 10.8% during the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 986,073 shares of the medical instruments supplier's stock after purchasing an additionalNovember 18, 2024 | marketbeat.comAngioDynamics Shareholder Approvals and Director ElectionsNovember 15, 2024 | markets.businessinsider.comAngioDynamics, Inc. (NASDAQ:ANGO) Short Interest UpdateAngioDynamics, Inc. (NASDAQ:ANGO - Get Free Report) was the target of a large decline in short interest in October. As of October 31st, there was short interest totalling 1,230,000 shares, a decline of 16.9% from the October 15th total of 1,480,000 shares. Based on an average daily trading volume, of 479,100 shares, the days-to-cover ratio is presently 2.6 days.November 15, 2024 | marketbeat.com3 Growth Stocks Under $10 That Analysts Predict Will SkyrocketNovember 15, 2024 | stocknews.comAngioDynamics (NASDAQ:ANGO) Share Price Crosses Above 200 Day Moving Average - What's Next?AngioDynamics (NASDAQ:ANGO) Shares Pass Above Two Hundred Day Moving Average - What's Next?November 12, 2024 | marketbeat.comInvestors in AngioDynamics (NASDAQ:ANGO) have unfortunately lost 77% over the last three yearsOctober 29, 2024 | finance.yahoo.comAngioDynamics (ANGO) Stock Dips Amidst Financial Performance ReviewOctober 25, 2024 | gurufocus.comQ2 EPS Estimates for AngioDynamics Reduced by Zacks ResearchAngioDynamics, Inc. (NASDAQ:ANGO - Free Report) - Stock analysts at Zacks Research lowered their Q2 2025 earnings estimates for AngioDynamics in a research report issued on Wednesday, October 23rd. Zacks Research analyst D. Dey now forecasts that the medical instruments supplier will post earningOctober 25, 2024 | marketbeat.comAngioDynamics and UCLH launch study of ‘long term effects’ of NanoKnife SystemOctober 24, 2024 | markets.businessinsider.comAngioDynamics (NASDAQ:ANGO) Stock Price Passes Above 200-Day Moving Average - Should You Sell?AngioDynamics (NASDAQ:ANGO) Stock Passes Above 200 Day Moving Average - Time to Sell?October 23, 2024 | marketbeat.comMarshall Wace LLP Sells 218,500 Shares of AngioDynamics, Inc. (NASDAQ:ANGO)Marshall Wace LLP reduced its position in shares of AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) by 76.4% in the second quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 67,457 shares of the medical instruments supplier's stock after selliOctober 11, 2024 | marketbeat.comAngioDynamics, Inc. (NASDAQ:ANGO) Shares Sold by AQR Capital Management LLCAQR Capital Management LLC lessened its stake in AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) by 23.6% in the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 310,312 shares of the medical instruments supplier's stock aOctober 10, 2024 | marketbeat.comAngioDynamics, Inc. (NASDAQ:ANGO) CEO Buys $120,600.00 in StockOctober 9, 2024 | insidertrades.comDimensional Fund Advisors LP Has $6.73 Million Stock Position in AngioDynamics, Inc. (NASDAQ:ANGO)Dimensional Fund Advisors LP lessened its holdings in shares of AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) by 17.9% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 1,112,910 shares of the medical instruments supplier's stoOctober 9, 2024 | marketbeat.comJames C. Clemmer Buys 20,000 Shares of AngioDynamics, Inc. (NASDAQ:ANGO) StockAngioDynamics, Inc. (NASDAQ:ANGO - Get Free Report) CEO James C. Clemmer purchased 20,000 shares of the business's stock in a transaction that occurred on Monday, October 7th. The shares were bought at an average price of $6.03 per share, for a total transaction of $120,600.00. Following the completion of the purchase, the chief executive officer now directly owns 681,582 shares in the company, valued at $4,109,939.46. This represents a 0.00 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.October 8, 2024 | marketbeat.comMillennium Management LLC Has $10.85 Million Stake in AngioDynamics, Inc. (NASDAQ:ANGO)Millennium Management LLC raised its stake in shares of AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) by 41.9% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,793,454 shares of the medical instruments supplier's stock afterOctober 8, 2024 | marketbeat.comHC Wainwright Comments on AngioDynamics, Inc.'s FY2026 Earnings (NASDAQ:ANGO)AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) - Equities researchers at HC Wainwright issued their FY2026 EPS estimates for AngioDynamics in a note issued to investors on Friday, October 4th. HC Wainwright analyst Y. Chen expects that the medical instruments supplier will post earnings of ($0.2October 7, 2024 | marketbeat.comAngioDynamics, Inc. (ANGO) Q1 2025 Earnings Call TranscriptOctober 5, 2024 | seekingalpha.comAngioDynamics (ANGO) Gets a Buy from H.C. WainwrightOctober 5, 2024 | markets.businessinsider.comAngioDynamics, Inc. (NASDAQ:ANGO) Q1 2025 Earnings Call TranscriptOctober 5, 2024 | msn.com4 Analysts Assess AngioDynamics: What You Need To KnowOctober 5, 2024 | benzinga.comAngioDynamics (NASDAQ:ANGO) Given "Buy" Rating at HC WainwrightHC Wainwright reissued a "buy" rating and issued a $14.00 price objective on shares of AngioDynamics in a report on Friday.October 4, 2024 | marketbeat.comAngioDynamics (NASDAQ:ANGO) Price Target Cut to $12.00Canaccord Genuity Group dropped their price target on AngioDynamics from $13.00 to $12.00 and set a "buy" rating on the stock in a research note on Friday.October 4, 2024 | marketbeat.comAngioDynamics (NASDAQ:ANGO) Issues Earnings Results, Beats Estimates By $0.04 EPSAngioDynamics (NASDAQ:ANGO - Get Free Report) released its earnings results on Thursday. The medical instruments supplier reported ($0.11) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.15) by $0.04. The company had revenue of $67.50 million for the quarter, compared to analysts' expectations of $67.93 million. AngioDynamics had a negative return on equity of 4.91% and a negative net margin of 61.55%. The firm's quarterly revenue was down 14.2% on a year-over-year basis. During the same quarter in the previous year, the firm posted ($0.12) EPS.October 4, 2024 | marketbeat.comAngioDynamics Shares Tumble as Company Swings to 1Q LossOctober 4, 2024 | marketwatch.comAngioDynamics Q1 Loss Beats Estimates, But Sales DownOctober 4, 2024 | markets.businessinsider.comAngioDynamics slides after Q1 revenue missOctober 4, 2024 | seekingalpha.comWhy AngioDynamics Stock Is Crashing TodayOctober 3, 2024 | fool.comAngioDynamics (NASDAQ:ANGO) Issues FY 2025 Earnings GuidanceAngioDynamics (NASDAQ:ANGO) updated its FY 2025 earnings guidance. The company provided EPS guidance of -0.420--0.380 for the period, compared to the consensus estimate of -0.410. The company also issued revenue guidance of $282.0 millionillion-$288.0 millionillion, compared to the consensus estimate of $284.4 millionillion.October 3, 2024 | marketbeat.comAngioDynamics Reports Fiscal Year 2025 First Quarter Financial ResultsOctober 3, 2024 | businesswire.comTop Wall Street Forecasters Revamp AngioDynamics Price Expectations Ahead Of Q1 EarningsOctober 3, 2024 | benzinga.comAngioDynamics Inc (ANGO) Q1 2025 Earnings Report Preview: What To ExpectOctober 2, 2024 | finance.yahoo.comHere's What Could Help AngioDynamics (ANGO) Maintain Its Recent Price StrengthSeptember 30, 2024 | finance.yahoo.comSystematic Financial Management LP Buys 162,972 Shares of AngioDynamics, Inc. (NASDAQ:ANGO)Systematic Financial Management LP raised its stake in AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) by 8.4% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 2,109,561 shares of the medical instruments supplier's stocSeptember 29, 2024 | marketbeat.comAngioDynamics (ANGO) Scheduled to Post Quarterly Earnings on ThursdayAngioDynamics (NASDAQ:ANGO) will be releasing earnings before the market opens on Thursday, October 3, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=631136)September 26, 2024 | marketbeat.comParadigm Capital Management Inc. NY Has $2.89 Million Position in AngioDynamics, Inc. (NASDAQ:ANGO)Paradigm Capital Management Inc. NY lessened its holdings in shares of AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) by 55.7% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 478,021 shares of the mediSeptember 24, 2024 | marketbeat.com Get AngioDynamics News Delivered to You Automatically Sign up to receive the latest news and ratings for ANGO and its competitors with MarketBeat's FREE daily newsletter. Email Address Why I'm telling friends to avoid gold stocks (Ad)Back in November, gold made a tiny move of 1.6%. But according to my backtesting by using a special type of gold trade, I would have seen a 141% gain in just a week. It happened again in March. Gold nudged up 1.2%. This time? A 104% overnight gain. And in June? A 1% gold move turned into a 74% gain in two weeks. Granted, there would have been smaller wins and those that did not work out, but you see, there's a reason I'm telling all my friends to hold off from buying gold or regular gold stocks right now. There's a more lucrative way to play the gold market as we enter a new breakout period. It's all about catching what I call "Acceleration Cycles." And if you’d like to get your hands on this, here you go, the complete breakdown. ANGO Media Mentions By Week ANGO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ANGO News Sentiment▼0.000.59▲Average Medical News Sentiment ANGO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ANGO Articles This Week▼23▲ANGO Articles Average Week Get AngioDynamics News Delivered to You Automatically Sign up to receive the latest news and ratings for ANGO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Alphatec News Today Orthofix Medical News Today Surmodics News Today Accuray News Today Rockwell Medical News Today ReShape Lifesciences News Today Abbott Laboratories News Today Intuitive Surgical News Today Stryker News Today Boston Scientific News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ANGO) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredVideo: Blindfolded Man Gets Into a Cybertruck… What Happens Next Will Shock You“Hi, I’m Jeff Brown… Even though I can’t see a thing… I’m about to get in this Cybertruck and drive up t...Brownstone Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AngioDynamics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AngioDynamics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ANGO Stock Alerts